By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS


Industry
Services

Segment
Publisher





Company News
Agendia BV Release: The New England Journal of Medicine Publishes MINDACT Trial Results Proving The Clinical Utility Of Mammaprint In Assisting Physicians To Identify Early-Stage Breast Cancer Patients Who Can Safely Forgo Chemotherapy 8/25/2016 8:49:21 AM
Pivotal Study Results Published In The New England Journal of Medicine Confirm Safety And Efficacy Of InSightec's Exablate Neuro System For The Treatment Of Essential Tremor 8/25/2016 6:56:24 AM
Intercept Pharma (ICPT) Release: The New England Journal of Medicine Publishes Results Of Phase III POISE Trial Of Ocaliva (Obeticholic Acid) For The Treatment Of PBC 8/18/2016 8:13:09 AM
Rhythm Announces The New England Journal of Medicine Publication Of Setmelanotide Phase 2 Data For Treatment Of POMC Deficiency Obesity 7/21/2016 6:31:10 AM
Puma Biotech (PBYI) Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal of Medicine 7/7/2016 10:51:30 AM
Cytel Publication In The New England Journal of Medicine Propels Adaptive Design Into The Mainstream Of Medical Research 7/7/2016 10:40:19 AM
Novartis AG (NVS) PKC412 (Midostaurin) Pivotal Data Published In The New England Journal of Medicine Show 60% Response Rate In Advanced Systemic Mastocytosis (SM) 6/30/2016 6:13:02 AM
Where Zika Virus Goes, Abortion Rates Grow, Study Published In The New England Journal of Medicine 6/24/2016 7:04:29 AM
Novartis Pharmaceuticals Canada Inc. Release: FLAME Study Evaluating Efficacy Of Ultibro Breezhaler To Reduce Chronic COPD Exacerbations Published In The New England Journal of Medicine 6/21/2016 6:36:39 AM
Studies Demonstrate Eli Lilly (LLY)'s Taltz (Ixekizumab) Maintained Or Achieved High Levels Of Skin Clearance For Patients With Moderate-To-Severe Plaque Psoriasis Through 60 Weeks: Results Published In The New England Journal of Medicine 6/9/2016 9:09:59 AM
12345678910...
//-->